Literature DB >> 8721566

Peripheral blood cell counts in infants with Down's syndrome.

S M Kivivuori1, J Rajantie, M A Siimes.   

Abstract

The current literature indicates that several abnormalities have been observed in the three hematopoietic cell lines of infants with Down's syndrome. This prospective, longitudinal study was designed to clarify the physiological variation in peripheral blood cell values of children with Down's syndrome by following 25 such infants during their first year of life. Apart from polycythemia in the first week of life, the hemoglobin concentration was, in general, the same as in normal term infants. At 9-12 months of age values for mean corpuscular hemoglobin and mean corpuscular volume tended to be elevated. Serum erythropoietin concentrations were low to normal. White blood cell counts were slightly lower in children with Down's syndrome than in normal children. The study infants had profound thrombocytosis from the age of 6 weeks to the end of follow-up at 1 year. This study, the first longitudinal follow-up of such subjects, indicates that infants with Down's syndrome often have evidence of polycythemia soon after birth and red blood cell macrocytosis and thrombocytosis later in infancy. In conclusion, we carried out peripheral blood cell counts in 25 infants with Down's syndrome, but with no actual hematological disturbance, during their first year of life, and compared them with values for normal term infants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721566     DOI: 10.1111/j.1399-0004.1996.tb04318.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

Review 1.  Hematological disorders and leukemia in children with Down syndrome.

Authors:  Annelyse Bruwier; Christophe F Chantrain
Journal:  Eur J Pediatr       Date:  2011-11-24       Impact factor: 3.183

2.  Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.

Authors:  Karen R Rabin; Justin Smith; Claudia A Kozinetz
Journal:  Pediatr Blood Cancer       Date:  2011-11-21       Impact factor: 3.167

3.  Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.

Authors:  Jennifer Keck-Wherley; Deepak Grover; Sharmistha Bhattacharyya; Xiufen Xu; Derek Holman; Eric D Lombardini; Ranjana Verma; Roopa Biswas; Zygmunt Galdzicki
Journal:  Dev Neurosci       Date:  2011-10-27       Impact factor: 2.984

4.  Prevalence of iron deficiency in children with Down syndrome.

Authors:  Natalia E Dixon; Blythe G Crissman; P Brian Smith; Sherri A Zimmerman; Gordon Worley; Priya S Kishnani
Journal:  J Pediatr       Date:  2010-07-21       Impact factor: 4.406

5.  The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.

Authors:  Alexander Zaslavsky; Stella T Chou; Keri Schadler; Allyson Lieberman; Maxim Pimkin; Yeo Jung Kim; Kwan-Hyuck Baek; William C Aird; Mitchell J Weiss; Sandra Ryeom
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

Review 6.  Haematology of Down syndrome.

Authors:  David Webb; Irene Roberts; Paresh Vyas
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-09-05       Impact factor: 5.747

7.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

8.  Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.

Authors:  Gina Kirsammer; Sarah Jilani; Hui Liu; Elizabeth Davis; Sandeep Gurbuxani; Michelle M Le Beau; John D Crispino
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

9.  Anemia in children with down syndrome.

Authors:  Ariel Tenenbaum; Sarah Malkiel; Isaiah D Wexler; Floris Levy-Khademi; Shoshana Revel-Vilk; Polina Stepensky
Journal:  Int J Pediatr       Date:  2011-09-14

10.  Comparison of Postoperative, In-Hospital Outcomes After Complete Repair of Tetralogy of Fallot Between 22q11.2 Deletion Syndrome and Trisomy 21.

Authors:  Timothy E Nissen; Isabella Zaniletti; R Thomas Collins; Lawrence E Greiten; Parthak Prodhan; Paul M Seib; Elijah H Bolin
Journal:  Pediatr Cardiol       Date:  2021-07-30       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.